A Prospective Study of Discomfort Symptoms in Patients With Aortic Disease After Endovascular Intervention
1 other identifier
observational
120
1 country
1
Brief Summary
The incidence and severity of post-procedural discomfort were evaluated in patients undergoing endovascular repair for aortic disease across six symptom-related dimensions: immobilization-related issues, puncture site discomfort, adhesive-induced skin reactions, post-stent implantation syndrome, impairment in self-care ability, and physical/psychological stress responses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 28, 2025
CompletedFirst Posted
Study publicly available on registry
August 11, 2025
CompletedStudy Start
First participant enrolled
January 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
August 11, 2025
July 1, 2025
1.9 years
July 28, 2025
August 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The incidence of postoperative discomfort symptoms
Based on six dimensions-immobilization-related, puncture site-related, adhesive-related skin reactions, aortic disease-related symptoms, self-care ability, and psychosomatic stress-patients were assessed at 6, 24, and 48 hours postoperatively using a structured questionnaire. The primary objective was to assess the incidence of postoperative complications and the severity of pain.
6, 24, and 48 hours postoperatively
Study Arms (1)
1
Patients with aortic disease who received endovascular treatment
Eligibility Criteria
Patients with aortic dissection undergoing endovascular treatment
You may qualify if:
- Diagnosed with thoracoabdominal aortic disease
- Patients who underwent endovascular treatment of the thoracoabdominal aorta via the femoral artery approach
You may not qualify if:
- Aortic disease caused by infection
- Aortic disease caused by trauma
- Aortic disease treated by open abdominal surgery
- Presence of systemic diseases uncontrollable by current medical standards (e.g., severe cardiac, pulmonary or hepatic dysfunction; advanced malignancy; cachexia; refractory severe coronary artery disease symptoms; coagulation disorders caused by genetic diseases, etc.)
- Patients who have undergone endovascular aortic treatment via femoral artery access prior to this procedure due to other diseases (not related to the current aortic disease)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The first affiliated hospital of Zhejiang University
Hangzhou, Zhejiang, 310003, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 28, 2025
First Posted
August 11, 2025
Study Start
January 1, 2026
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
August 11, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL